Please enable JavaScript to continue using this application.

Compare $CGEM vs $MNKD | Chartloom

Compare

$CGEM vs $MNKD

Cullinan Therapeutics Inc · MannKind Corp

CGEM

Cullinan Therapeutics Inc

MNKD

MannKind Corp

Compare $CGEM vs $MNKD

Comparing Cullinan Therapeutics Inc and MannKind Corp

CGEMCullinan Therapeutics Inc

MNKDMannKind Corp

CGEMCullinan Therapeutics Inc

Market cap

$954M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.5%

52W performance

140.8%

FCF yield

-16.7%

MNKDMannKind Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.01x

Rev growth (TTM)

30.5%

YTD performance

-41.3%

52W performance

-39.5%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGEM

MNKD

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

MNKD

MannKind Corp

Market Cap

CGEM$954M

MNKD$1.05B

Enterprise Value

CGEM$876M

MNKD$1.57B

Price

CGEM$15.53

MNKD$3.29

P/E Ratio

CGEMN/A

MNKDN/A

P/S Ratio

CGEM0.00x

MNKD2.67x

EV/Sales

CGEM0.00x

MNKD3.98x

EV/EBITDA

CGEM8.02x

MNKD43.92x

P/B Ratio

CGEM3.10x

MNKD69.42x

P/FCF Ratio

CGEMN/A

MNKDN/A

EV/FCF

CGEM-5.50x

MNKD-86.45x

PEG Ratio

CGEMN/A

MNKDN/A

Forward P/E (NTM)

CGEMN/A

MNKDN/A

Forward P/S (NTM)

CGEMN/A

MNKD2.01x

Revenue (TTM)

CGEM$0

MNKD$394M

Revenue Growth (YoY)

CGEMN/A

MNKD30.5%

Forward Rev Growth

CGEM244.6%

MNKD13.7%

Gross Margin (TTM)

CGEM0.0%

MNKD76.8%

Operating Margin (TTM)

CGEM0.0%

MNKD2.3%

EBITDA Margin (TTM)

CGEM0.0%

MNKD8.7%

Net Margin (TTM)

CGEM0.0%

MNKD-10.9%

FCF Margin (TTM)

CGEMN/A

MNKD-4.6%

Net Income (TTM)

CGEM$-205M

MNKD$-43M

FCF (TTM)

CGEM$-159M

MNKD$-18M

EPS (TTM)

CGEM-$3.33

MNKD-$0.14

ROE (TTM)

CGEM-5289.0%

MNKD-29771.0%

ROA (TTM)

CGEM-4818.0%

MNKD-619.0%

ROIC (TTM)

CGEM-5289.0%

MNKD-2719.0%

Cash

CGEM$79M

MNKD$53M

Debt

CGEM$0

MNKD$570M

Net Cash/Debt

CGEM$79M

MNKD$-517M

Current Ratio (TTM)

CGEM8.42x

MNKD1.72x

Quick Ratio (TTM)

CGEM8.23x

MNKD1.29x

Debt/Equity (TTM)

CGEM0.00x

MNKD9.95x

Debt/Assets (TTM)

CGEM0.0%

MNKD0.0%

Interest Coverage (TTM)

CGEMN/A

MNKDN/A

Net Debt/EBITDA (TTM)

CGEM0.00x

MNKD0.00x

Beta

CGEM-0.03

MNKD1.09

52W Performance

CGEM140.8%

MNKD-39.5%

YTD Performance

CGEM53.5%

MNKD-41.3%

% from 52W High

CGEM-33.0%

MNKD-49.5%

% from 52W Low

CGEM138.9%

MNKD47.5%

Asset Turnover (TTM)

CGEM0.00x

MNKD0.57x

FCF Yield (TTM)

CGEM-16.7%

MNKD-1.7%

Earnings Yield (TTM)

CGEM-21.4%

MNKD-4.1%

Dividend Yield (TTM)

CGEMN/A

MNKDN/A

Rule of 40

CGEM0.0

MNKD25.8

EV/GP/RG

CGEMN/A

MNKD0.15

Ticker research

View CGEM research View MNKD research

Metric	CGEM Cullinan Therapeutics Inc	MNKD MannKind Corp
Market & Valuation
Market Cap	$954M	$1.05B
Enterprise Value	$876M	$1.57B
Price	$15.53	$3.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.67x
EV/Sales	0.00x	3.98x
EV/EBITDA	8.02x	43.92x
P/B Ratio	3.10x	69.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.50x	-86.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.01x
Revenue & Growth
Revenue (TTM)	$0	$394M
Revenue Growth (YoY)	N/A	30.5%
Forward Rev Growth	244.6%	13.7%
Profitability
Gross Margin (TTM)	0.0%	76.8%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	0.0%	8.7%
Net Margin (TTM)	0.0%	-10.9%
FCF Margin (TTM)	N/A	-4.6%
Net Income (TTM)	$-205M	$-43M
FCF (TTM)	$-159M	$-18M
EPS (TTM)	-$3.33	-$0.14
ROE (TTM)	-5289.0%	-29771.0%
ROA (TTM)	-4818.0%	-619.0%
ROIC (TTM)	-5289.0%	-2719.0%
Financial Health
Cash	$79M	$53M
Debt	$0	$570M
Net Cash/Debt	$79M	$-517M
Current Ratio (TTM)	8.42x	1.72x
Quick Ratio (TTM)	8.23x	1.29x
Debt/Equity (TTM)	0.00x	9.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	1.09
52W Performance	140.8%	-39.5%
YTD Performance	53.5%	-41.3%
% from 52W High	-33.0%	-49.5%
% from 52W Low	138.9%	47.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.57x
FCF Yield (TTM)	-16.7%	-1.7%
Earnings Yield (TTM)	-21.4%	-4.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	25.8
EV/GP/RG	N/A	0.15
Ticker research	View CGEM research	View MNKD research

Valuation

P/S Ratio

CGEM

0.00x

MNKD

2.67x

EV/FCF

MNKD

-86.45x

CGEM

-5.50x

Growth & revenue

Revenue Growth TTM

MNKD

30.5%

Forward Revenue Growth

CGEM

244.6%

MNKD

13.7%

Profitability & performance

Gross Margin

MNKD

76.8%

CGEM

0.0%

ROE

CGEM

-5289.0%

MNKD

-29771.0%

FCF Yield %

MNKD

-1.7%

CGEM

-16.7%

52-Week Performance

CGEM

140.8%

MNKD

-39.5%

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

MNKD

MannKind Corp

Market Cap

CGEM$954M

MNKD$1.05B

Enterprise Value

CGEM$876M

MNKD$1.57B

Price

CGEM$15.53

MNKD$3.29

P/E Ratio

CGEMN/A

MNKDN/A

P/S Ratio

CGEM0.00x

MNKD2.67x

EV/Sales

CGEM0.00x

MNKD3.98x

EV/EBITDA

CGEM8.02x

MNKD43.92x

P/B Ratio

CGEM3.10x

MNKD69.42x

P/FCF Ratio

CGEMN/A

MNKDN/A

EV/FCF

CGEM-5.50x

MNKD-86.45x

PEG Ratio

CGEMN/A

MNKDN/A

Forward P/E (NTM)

CGEMN/A

MNKDN/A

Forward P/S (NTM)

CGEMN/A

MNKD2.01x

Revenue (TTM)

CGEM$0

MNKD$394M

Revenue Growth (YoY)

CGEMN/A

MNKD30.5%

Forward Rev Growth

CGEM244.6%

MNKD13.7%

Gross Margin (TTM)

CGEM0.0%

MNKD76.8%

Operating Margin (TTM)

CGEM0.0%

MNKD2.3%

EBITDA Margin (TTM)

CGEM0.0%

MNKD8.7%

Net Margin (TTM)

CGEM0.0%

MNKD-10.9%

FCF Margin (TTM)

CGEMN/A

MNKD-4.6%

Net Income (TTM)

CGEM$-205M

MNKD$-43M

FCF (TTM)

CGEM$-159M

MNKD$-18M

EPS (TTM)

CGEM-$3.33

MNKD-$0.14

ROE (TTM)

CGEM-5289.0%

MNKD-29771.0%

ROA (TTM)

CGEM-4818.0%

MNKD-619.0%

ROIC (TTM)

CGEM-5289.0%

MNKD-2719.0%

Cash

CGEM$79M

MNKD$53M

Debt

CGEM$0

MNKD$570M

Net Cash/Debt

CGEM$79M

MNKD$-517M

Current Ratio (TTM)

CGEM8.42x

MNKD1.72x

Quick Ratio (TTM)

CGEM8.23x

MNKD1.29x

Debt/Equity (TTM)

CGEM0.00x

MNKD9.95x

Debt/Assets (TTM)

CGEM0.0%

MNKD0.0%

Interest Coverage (TTM)

CGEMN/A

MNKDN/A

Net Debt/EBITDA (TTM)

CGEM0.00x

MNKD0.00x

Beta

CGEM-0.03

MNKD1.09

52W Performance

CGEM140.8%

MNKD-39.5%

YTD Performance

CGEM53.5%

MNKD-41.3%

% from 52W High

CGEM-33.0%

MNKD-49.5%

% from 52W Low

CGEM138.9%

MNKD47.5%

Asset Turnover (TTM)

CGEM0.00x

MNKD0.57x

FCF Yield (TTM)

CGEM-16.7%

MNKD-1.7%

Earnings Yield (TTM)

CGEM-21.4%

MNKD-4.1%

Dividend Yield (TTM)

CGEMN/A

MNKDN/A

Rule of 40

CGEM0.0

MNKD25.8

EV/GP/RG

CGEMN/A

MNKD0.15

Ticker research

View CGEM research View MNKD research

Metric	CGEM Cullinan Therapeutics Inc	MNKD MannKind Corp
Market & Valuation
Market Cap	$954M	$1.05B
Enterprise Value	$876M	$1.57B
Price	$15.53	$3.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.67x
EV/Sales	0.00x	3.98x
EV/EBITDA	8.02x	43.92x
P/B Ratio	3.10x	69.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.50x	-86.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.01x
Revenue & Growth
Revenue (TTM)	$0	$394M
Revenue Growth (YoY)	N/A	30.5%
Forward Rev Growth	244.6%	13.7%
Profitability
Gross Margin (TTM)	0.0%	76.8%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	0.0%	8.7%
Net Margin (TTM)	0.0%	-10.9%
FCF Margin (TTM)	N/A	-4.6%
Net Income (TTM)	$-205M	$-43M
FCF (TTM)	$-159M	$-18M
EPS (TTM)	-$3.33	-$0.14
ROE (TTM)	-5289.0%	-29771.0%
ROA (TTM)	-4818.0%	-619.0%
ROIC (TTM)	-5289.0%	-2719.0%
Financial Health
Cash	$79M	$53M
Debt	$0	$570M
Net Cash/Debt	$79M	$-517M
Current Ratio (TTM)	8.42x	1.72x
Quick Ratio (TTM)	8.23x	1.29x
Debt/Equity (TTM)	0.00x	9.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	1.09
52W Performance	140.8%	-39.5%
YTD Performance	53.5%	-41.3%
% from 52W High	-33.0%	-49.5%
% from 52W Low	138.9%	47.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.57x
FCF Yield (TTM)	-16.7%	-1.7%
Earnings Yield (TTM)	-21.4%	-4.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	25.8
EV/GP/RG	N/A	0.15
Ticker research	View CGEM research	View MNKD research